A simple urine test may save the lives of thousands who lose their lives each year due to pancreatic cancer. According to British media, including the Irish Times, researchers at Queen Mary University in London have found a method that can successfully identify pancreatic cancer at a very early stage by detecting three proteins in urine. Pancreatic cancer is a progressive disease that disrupts the function of the pancreas, and while it can occur at all ages, it is most prevalent in individuals aged 55 to 85. Because the early symptoms of this cancer, such as skin itching, back pain, and acid reflux, can be mistaken for other diseases, researchers have dubbed it 'a wolf in sheep's clothing.' This recent advancement is significant because the symptoms of pancreatic cancer, which overlap with many other diseases, lead doctors to incorrect diagnoses and consequently incorrect treatments, making it often undetectable until the disease is very advanced—resulting in very little chance of treatment. Therefore, pancreatic cancer is one of the deadliest cancers, with only three percent of patients having a chance of recovery. This new discovery is crucial; when the disease is diagnosed in its early stages, a simple surgical procedure can increase the hope of recovery from three percent to sixty percent. Although a specific cause for this disease has not yet been identified, researchers believe that individuals with a family history of this cancer (hereditary), as well as those who are very obese and smokers, are at a higher risk of developing pancreatic cancer. Notable individuals who have died from pancreatic cancer include Steve Jobs, the founder of Apple, Pavarotti, the Italian opera singer, and Patrick Swayze, the Hollywood actor known for his role in 'Ghost.' According to data from the Iranian Cancer Research, Education, and Prevention Institute, as of 2006, the total number of pancreatic cancer cases in Iran was 293, with 114 cases reported in women and 179 in men.
Discovery of a New Method for Detecting Pancreatic Cancer
Researchers at Queen Mary University in London have developed a urine test that can detect pancreatic cancer at an early stage by identifying three proteins. This breakthrough is significant as it could increase the survival rate from three percent to sixty percent if diagnosed early. The discovery is crucial given the high mortality rate associated with pancreatic cancer.
👥 Key Players
📰 What Happened
Researchers at Queen Mary University in London have developed a urine test that can detect pancreatic cancer at an early stage by identifying three proteins. This breakthrough could significantly increase survival rates if the cancer is diagnosed early.
- Pancreatic cancer has a very low survival rate of three percent when diagnosed late.
- Early detection through this new method could raise the survival rate to sixty percent.
💡 Why It Matters
📚 Background
Pancreatic cancer is often diagnosed late due to non-specific symptoms, making early detection crucial for effective treatment.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%